Another Watertown Biotech Goes Public via Reverse Merger, and a Flurry of Leasing at the Arsenal
Plus Biolabs expansion and Labshare's new tenants
Watertown's First Potential IPO since 2023, Remix's Positive Clinical Trial Results, and Triveni Jumps into the Eczema Market
Plus the initial dosing of Enanta and Avencell's Clinical Trials